IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 238 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $258,727 | -86.0% | 36,751 | -87.9% | 0.00% | -88.9% |
| Q1 2023 | $1,848,384 | -71.0% | 302,518 | -69.7% | 0.02% | -66.0% |
| Q4 2022 | $6,377,859 | +284.7% | 998,100 | +476.3% | 0.05% | +278.6% |
| Q3 2022 | $1,658,000 | -26.6% | 173,183 | +89.0% | 0.01% | -39.1% |
| Q3 2021 | $2,260,000 | +845.6% | 91,641 | +896.1% | 0.02% | +666.7% |
| Q2 2021 | $239,000 | -74.4% | 9,200 | -68.8% | 0.00% | -72.7% |
| Q1 2021 | $935,000 | +141.6% | 29,501 | +254.1% | 0.01% | +120.0% |
| Q4 2020 | $387,000 | -76.9% | 8,332 | -83.7% | 0.01% | -84.4% |
| Q3 2020 | $1,678,000 | -29.5% | 50,969 | -41.2% | 0.03% | 0.0% |
| Q2 2020 | $2,380,000 | +555.6% | 86,718 | +614.6% | 0.03% | +39.1% |
| Q1 2020 | $363,000 | -94.2% | 12,135 | -94.7% | 0.02% | -85.0% |
| Q4 2019 | $6,278,000 | +141.8% | 226,851 | +59.1% | 0.15% | +101.3% |
| Q3 2019 | $2,596,000 | +435.3% | 142,600 | +620.2% | 0.08% | +347.1% |
| Q2 2019 | $485,000 | -73.0% | 19,800 | -89.5% | 0.02% | -72.6% |
| Q1 2019 | $1,793,000 | -78.4% | 188,430 | -79.9% | 0.06% | -80.6% |
| Q4 2018 | $8,304,000 | +1564.1% | 938,300 | +3076.3% | 0.32% | +762.2% |
| Q1 2018 | $499,000 | +99.6% | 29,541 | -13.2% | 0.04% | +42.3% |
| Q2 2017 | $250,000 | – | 34,024 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,222,701 | $25,005,000 | 8.92% |
| Broadfin Capital, LLC | 4,894,361 | $55,062,000 | 8.10% |
| GREAT POINT PARTNERS LLC | 3,496,340 | $39,334,000 | 6.13% |
| FRAZIER MANAGEMENT LLC | 2,188,331 | $24,619,000 | 4.51% |
| Prosight Management, LP | 715,317 | $8,047,000 | 4.49% |
| Avoro Capital Advisors LLC | 8,662,720 | $97,456,000 | 4.48% |
| QVT Financial LP | 821,361 | $8,748,000 | 2.26% |
| Perceptive Advisors | 7,290,199 | $82,014,000 | 2.19% |
| Rhenman & Partners Asset Management AB | 1,290,495 | $14,518,000 | 1.46% |
| EMORY UNIVERSITY | 185,915 | $2,092,000 | 1.37% |